Skip to Main Content

Paper Details

Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Alzheimers Dement
9
2023
AD, AD dementia, Alzheimer's Disease, Alzheimer's disease, EOAD, EOnonAD, Florbetaben, MCI, Tau, [18F]Florbetaben, [18F]Flortaucipir, amyloid-beta, cognitive impairment, cognitively impaired, participants, patients, tau
Author NameAffiliation
Liana G ApostolovaIndiana University School of Medicine
Liana G ApostolovaCenter for Neuroimaging, Indiana University School of Medicine Indianapolis
Liana G ApostolovaIndiana University School of Medicine
Tatiana ForoudIndiana University School of Medicine
Clifford R JackMayo Clinic
Joel H KramerUCSF Weill Institute for Neurosciences, University of California san francisco
Arthur W TogaUSC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC
Arthur W TogaUSC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC
Ranjan DuaraWien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center
Neill R Graff-RadfordMayo Clinic
Lawrence S HonigTaub Institute and Department of Neurology, Columbia University Irving Medical Center
Chiadi U OnyikeJohns Hopkins University School of Medicine
Stephen SallowayAlpert Medical School, Brown University
Raymond S TurnerGeorgetown University
Robert A KoeppeUniversity of Michigan ann arbor
  • 1 - 15

Datasets

Release 1.2